Management of Neuropsychiatric Symptoms of Dementia: A Comprehensive Review of the Current Literature
Authors:
- Laura SuarezLSLaura Suarez
- Reem M.A. ShafiRSReem M.A. Shafi
- Maria I. LapidMLMaria I. Lapid
Open Access
- 16 September 2019
- journal article
- review article
- Published by LIDSEN Publishing Inc in OBM Geriatrics
- Vol. 03 (03) , 1-21
Abstract
Background: Dementia is a progressive and debilitating condition that affects millions of patients in the United States with an enormous impact on healthcare costs, caregivers, and society. Patients with dementia often experience dementia-related neuropsychiatric disturbances, commonly known as Behavioral and Psychological Symptoms of Dementia (BPSD) and more recently Neuropsychiatric symptoms (NPS) in dementia. These symptoms include verbal and physical agitation, aggression, disinhibition, affect lability, apathy, psychosis, depression, and anxiety. Symptom management is important to optimize quality of life, minimize further functional decline, and delay institutionalization. We aim to review the existing published literature on pharmacologic and non-pharmacologic management of NPS. Methods: PubMed, Google Scholar, and Cochrane were searched for available reviews, systematic reviews, meta-analysis, and randomized controlled trials on diagnostic tools and treatment strategies for NPS. Some of the searched terms used included, “neuropsychiatric symptoms of dementia treatment,” “NPS treatment,” “pharmacologic treatment NPS,” “non-pharmacologic treatment NPS,” “scales NPS.” We also searched for the term “BPSD” instead of “NPS” and “neurocognitive disorder” instead of “dementia.” Recent Findings: There are different treatment modalities to address NPS, including pharmacologic and non-pharmacologic approaches, but the evidence throughout the years has been controversial and mostly studied in Alzheimer’s disease population making less generalizable to other dementia populations. Summary: NPS continues to be a prevalent and debilitating condition in the elderly population with dementia. Non-pharmacologic strategies continue to be the first-line treatment for NPS despite lack of strong evidence because of their potential benefit and absence of side effects. Conversely, pharmacologic strategies have a potential risk for side effects in addition to the lack of strong evidence about their benefits in NPS; therefore, deprescribing is an important consideration in the management of these patients.Keywords
This publication has 93 references indexed in Scilit:
- Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of DementiaJAMA Network Open, 2019
- Valproate preparations for agitation in dementiaCochrane Database of Systematic Reviews, 2018
- Antidepressants for treating depression in dementiaCochrane Database of Systematic Reviews, 2018
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease DementiaJAMA, 2015
- Effect of Citalopram on Agitation in Alzheimer DiseaseJAMA, 2014
- The effect of music therapy compared with general recreational activities in reducing agitation in people with dementia: a randomised controlled trialInternational Journal of Geriatric Psychiatry, 2012
- Nonpharmacologic Management of Behavioral Symptoms in DementiaJAMA, 2012
- Antipsychotic Use and Myocardial Infarction in Older Patients With Treated DementiaArchives of internal medicine (1960), 2012
- Antidepressants for agitation and psychosis in dementiaCochrane Database of Systematic Reviews, 2011
- Antidepressants for treating depression in dementiaCochrane Database of Systematic Reviews, 2002